Tel:01326 558714
Email:
building
Welcome to Meneage Street Surgery
Welcome to the Meneage Street Surgery website, where you can find information about the Surgery, the doctors and staff, as well as the services and clinics we offer, all available via the menu above. Our latest news is displayed below, with the full news history shown on the news page.
We are currently adding content to the site, so check back often!
divider
News Items from the Last Month
COVID VACCINATIONS
posted 26 February 2021 13:00

The surgery is receiving many questions about second doses of COVID vaccination. We are eager to know about second doses, but we have not yet been given the vaccine delivery dates, so we cannot plan clinic dates at the moment.

We have been told that the second dose date will be around 11-12 weeks after a patient's first vaccination date. As soon as we have more information you will be informed of clinic availability and be invited to book.

Thank you for bearing with us.

COVID-19 Vaccination Update - Cohort 6
posted 23 February 2021 18:59

We appreciate that the Covid guidance can be quite confusing and raises some questions about who is and isn't eligible.  Below is some information which outlines who falls into this cohort. We will be inviting in those that fall into these groups, you do not need to call or email us. The only people who need to contact are those in the 65-69 category who cannot get to a mass vaccination site eg Stithians. 

Clinical risk groups 16 years of age and over who should receive COVID-19 immunisation

 Chronic respiratory disease

Individuals with a severe lung condition, including those with asthma that requires continuous or repeated use of systemic steroids or with previous exacerbations requiring hospital admission, and chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema; bronchiectasis, cystic fibrosis, interstitial lung fibrosis, pneumoconiosis and bronchopulmonary dysplasia (BPD).

Chronic heart disease and vascular disease

Congenital heart disease, hypertension with cardiac complications, chronic heart failure, individuals requiring regular medication and/or follow-up for ischaemic heart disease. This includes individuals with atrial fibrillation, peripheral vascular disease or a history of venous thromboembolism.

Chronic kidney disease

Chronic kidney disease at stage 3, 4 or 5, chronic kidney failure, nephrotic syndrome, kidney transplantation.

Chronic liver disease

Cirrhosis, biliary atresia, chronic hepatitis.

Chronic neurological disease

Stroke, transient ischaemic attack (TIA). Conditions in which respiratory function may be compromised due to neurological disease (e.g. polio syndrome sufferers). This includes individuals with cerebral palsy, severe or profound learning disabilities, Down’s Syndrome, multiple sclerosis, epilepsy, dementia, Parkinson’s disease, motor neurone disease and related or similar conditions; or hereditary and degenerative disease of the nervous system or muscles; or severe neurological disability.

Diabetes mellitus

Any diabetes, including diet-controlled diabetes.

Immunosuppression

Immunosuppression due to disease or treatment, including patients undergoing chemotherapy leading to immunosuppression, patients undergoing radical radiotherapy, solid organ transplant recipients, bone marrow or stem cell transplant recipients, HIV infection at all stages, multiple myeloma or genetic disorders affecting the immune system (e.g. IRAK-4, NEMO, complement disorder, SCID).

Individuals who are receiving immunosuppressive or immunomodulating biological therapy including, but not limited to, anti-TNF, alemtuzumab, ofatumumab, rituximab, patients receiving protein kinase inhibitors or PARP inhibitors, and individuals treated with steroid sparing agents such as cyclophosphamide and mycophenolate mofetil.

Individuals treated with or likely to be treated with systemic steroids for more than a month at a dose equivalent to prednisolone at 20mg or more per day.

Anyone with a history of haematological malignancy, including leukaemia, lymphoma, and myeloma and those with systemic lupus erythematosus and rheumatoid arthritis, and psoriasis who may require long term immunosuppressive treatments.

Some immunosuppressed patients may have a suboptimal immunological response to the vaccine.

Asplenia or dysfunction of the spleen

This also includes conditions that may lead to splenic dysfunction, such as homozygous sickle cell disease, thalassemia major and coeliac syndrome.

Morbid obesity

Adults with a Body Mass Index ≥40 kg/m².

Severe mental illness

Individuals with schizophrenia or bipolar disorder, or any mental illness that causes severe functional impairment.

Adult carers

Those who are in receipt of a carer’s allowance, or those who are the main carer of an elderly or disabled person whose welfare may be at risk if the carer falls ill.

Younger adults in long-stay nursing and

Many younger adults in residential care settings will be eligible for vaccination because they fall into one of the clinical risk groups above.

COVID-19 vaccination
posted 08 February 2021 18:24

If you are registered at the surgery, aged 70 and over, and have not had a first COVID-19 vaccination, please do get in contact with the practice.



divider
• CQC Quality Report